Promacta

Main information

  • Trade name:
  • Promacta 75mg tablets
  • Pharmaceutical form:
  • Tablet (385055001)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Promacta 75mg tablets
    United Kingdom
  • Language:
  • English

Other information

Status

  • Source:
  • eMC
  • Last update:
  • 01-12-2017

9-11-2018

Medical Devices Safety Update, Volume 6, Number 6, November 2018

Medical Devices Safety Update, Volume 6, Number 6, November 2018

Standards minimise risk of misconnections; eltrombopag interference with test results; amniotic fluid tests

Therapeutic Goods Administration - Australia

10-7-2018

Revolade (Novartis Europharm Limited)

Revolade (Novartis Europharm Limited)

Revolade (Active substance: Eltrombopag) - PSUSA - Modification - Commission Decision (2018)4487 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1205/201709

Europe -DG Health and Food Safety